Gains Network vs Injective — how do they compare? Gains Network trades at Rp9,352 (market cap Rp218,31M, Rp6,04M 24h volume), while Injective trades at Rp75,554 (market cap Rp7,49T, Rp831,89M 24h volume). The key difference: Injective is far larger — about 34309× Gains Network's market cap, and Gains Network's circulating supply is 23,4M GNS versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Gains Network for 47 Days and Injective for 37 Days on average.
| GNS | INJ | |
|---|---|---|
Market Cap | Rp218,31M | Rp7,49T |
Volume (24h) | Rp6,04M | Rp831,89M |
Circulating Supply | 23,4M GNS | 100M INJ |
Typical Hold Time | 47 Days | 37 Days |
Signals from Pluang's Aura AI — not financial advice
Gains Network (GNS) is trading at Rp9,382 with a market cap of Rp219.2 million, showing a bullish technical signal despite bearish moving averages. The token is near key support at Rp9,260, with RSI_6 indicating overbought conditions at 86.88. Recent on-chain data shows an average hold time of 47 days, suggesting moderate holder commitment. No major protocol upgrades or ecosystem developments were reported recently, keeping fundamental activity subdued.
Overall outlook is cautiously optimistic due to bullish momentum, but risks include high volatility from low liquidity and regulatory uncertainties in crypto markets. Key opportunities lie in potential breakout above resistance at Rp9,533, while major risks involve price sensitivity to low trading volumes and broader market sentiment shifts.
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Gains Network is developing gTrade, a liquidity-efficient, powerful, and user-friendly decentralized leveraged trading platform. The protocol revolves around the ecosystem's ERC20 utility token (GNS) and ERC721 utility token (NFTs). It is a DAO governed by the $GNS token with the goal to create DeFi products that bring revenue that can be distributed in a $GNS staking pool.
Read more on GNS →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →